Health · 1 sources covering this

Why honesty is not always the best policy

Should you tell your boss she's got food on her face? Your partner you hate their outfit? Social psychologist Vanessa Bohns shares advice on when to tell someone the truth — or keep your mouth shut.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

NPRLean L·5h ago
Why honesty is not always the best policy
Should you tell your boss she's got food on her face? Your partner you hate their outfit? Social psychologist Vanessa Bohns shares advice on when to tell someone the truth — or keep your mouth shut.
Read at NPR →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/7ef162696af86d30656e833d6a3777c3c4e9c669"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Why honesty is not always the best policy"></iframe>

Why honesty is not always the best policy

How 1 sources are covering this

Why honesty is not always the best policy

More from Health

STAT+: GLP-1s are given an FDA warning for rare eye condition risk

STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug

STAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds

Reader

Trust & legal

Across the network

How 1 sources are covering this

Why honesty is not always the best policy

More from Health

STAT+: GLP-1s are given an FDA warning for rare eye condition risk

STAT+: Pharmalittle: We&#8217;re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug

STAT+: Pharma is a &#8216;mixed bag&#8217; when providing drug access to low- and middle-income countries, analysis finds

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more

STAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds